Anna Gawlicka

Anna is an accomplished clinical research executive; deeply experienced in the design, execution, analysis, and write-up of complex clinical trials. She has more than 20 years of experience in strategic planning and execution of clinical development programs in the US and OUS to support product development, regulatory approvals, and commercialization efforts. Most recently, she was Vice President, Clinical Affairs at Intersect ENT (upper respiratory/sinuses) where she worked to deliver clinical data to support PMA/NDA product approvals and indication expansions. Before this, Anna was Vice President, Clinical Affairs at Setpoint Medical (neuromodulation to treat autoimmune diseases), and earlier in her career, she led clinical research programs of therapeutic medical devices for gastrointestinal issues (e.g., obesity and gastroesophageal reflux disease/GERD). Anna received her Ph.D. from Laval University, Quebec City, Canada. She earned her MBA, with a focus on Healthcare, from the University of California at Irvine, and she has three additional master's or equivalent degrees from universities in the US, France, and Poland.